Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
Ann Bot ; 116(4): 669-78, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26346716

ABSTRACT

BACKGROUND AND AIMS: Loss of seed viability has been associated with deteriorative processes that are partly caused by oxidative damage. The breaking of dormancy, a seed trait that prevents germination in unfavourable seasons, has also been associated with oxidative processes. It is neither clear how much overlap exists between these mechanisms nor is the specific roles played by oxygen and reactive oxygen species. METHODS: Antioxidant profiles were studied in fresh (dormant) or after-ripened (non-dormant) sunflower (Helianthus annuus) embryos subjected to controlled deterioration at 40 °C and 75 % relative humidity under ambient (21 %) or high O2 (75 %). Changes in seed vigour and viability, dormancy, protein carbonylation and fatty acid composition were also studied. KEY RESULTS: After-ripening of embryonic axes was accompanied by a shift in the thiol-based cellular redox environment towards more oxidizing conditions. Controlled deterioration under high O2 led to a faster loss of seed dormancy and significant decreases in glutathione reductase and glutathione peroxidase activities, but viability was lost at the same rate as under ambient O2. Irrespective of O2 concentration, the overall thiol-based cellular redox state increased significantly over 21 d of controlled deterioration to strongly oxidizing conditions and then plateaued, while viability continued to decrease. Viability loss was accompanied by a rapid decrease in glucose-6-phosphate-dehydrogenase, which provides NADPH for reductive processes such as required by glutathione reductase. Protein carbonylation, a marker of protein oxidation, increased strongly in deteriorating seeds. The lipid-soluble tocochromanols, dominated by α-tocopherol, and fatty acid profiles remained stable. CONCLUSIONS: After-ripening, dormancy-breaking during ageing and viability loss appeared to be associated with oxidative changes of the cytosolic environment and proteins in the embryonic axis rather than the lipid environment. High O2 concentrations accelerated dormancy alleviation but, surprisingly, did not accelerate the rate of viability loss.


Subject(s)
Helianthus/growth & development , Oxygen/metabolism , Seeds/growth & development , Antioxidants/metabolism , Fatty Acids/metabolism , Glutathione/metabolism , Helianthus/metabolism , Oxidation-Reduction , Plant Dormancy , Protein Carbonylation , Seeds/metabolism , Vitamin E/metabolism
2.
HIV Med ; 7(2): 99-104, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16420254

ABSTRACT

OBJECTIVE: Few data exist on the efficacy of antiretroviral therapy in individuals infected with HIV in the Caribbean. We evaluated the virological and immunological responses of HIV-infected adults starting highly active antiretroviral therapy (HAART). DESIGN: This was a prospective observational cohort study. METHODS: A total of 158 antiretroviral-naive patients who initiated HAART between January 2002 and March 2003, and completed at least 6 months of treatment and follow up, were included in the analysis. The response to therapy was assessed by changes in CD4 cell counts and viral loads from baseline. The mean increase in CD4 cell count, the rate of virological success (a viral load of <50 HIV-1 RNA copies/mL) and the rate of immunological success (an increase in CD4 cell count of > or =50 cells/microL over the baseline value) after commencing HAART were measured. RESULTS: In total, 82% of patients (123 of 150) achieved viral loads of <50 copies/mL after 6 months of therapy. Viral success rate after 6 months of HAART was similar irrespective of gender, pre-HAART CD4 cell count and pre-HAART viral load. However, patients older than 40 years were significantly more likely to achieve virological success than those younger than 40 years. At 6 months after starting HAART, 79.5% of patients were estimated to have achieved immunological success and 17.9% had an increase in CD4 cell count of > or =200 cells/microL over the baseline value. The median increase in CD4 cell count for the 156 patients who had CD4 cell counts at baseline and at 6 months of therapy was 122 cells/microL. CONCLUSION: In this cohort of antiretroviral-naive HIV-infected adults, there was a high rate of virological and immunological success after 6 months of HAART, irrespective of the pre-HAART viral load and CD4 cell count.


Subject(s)
Developing Countries , HIV Infections/drug therapy , HIV-1 , Adult , Age Factors , Antiretroviral Therapy, Highly Active , Barbados , CD4 Lymphocyte Count , Drug Evaluation , Female , HIV Infections/immunology , HIV Infections/virology , HIV-1/isolation & purification , Humans , Male , Middle Aged , Prospective Studies , RNA, Viral/blood , Treatment Outcome , Viral Load
3.
J Virol ; 78(5): 2187-200, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14963115

ABSTRACT

Although there is increasing evidence that virus-specific cytotoxic-T-lymphocyte (CTL) responses play an important role in the control of human immunodeficiency virus (HIV) replication in vivo, only scarce CTL data are available for the ethnic populations currently most affected by the epidemic. In this study, we examined the CD8(+)-T-cell responses in African-American, Caucasian, Hispanic, and Caribbean populations in which clade B virus dominates and analyzed the potential factors influencing immune recognition. Total HIV-specific CD8(+)-T-cell responses were determined by enzyme-linked immunospot assays in 150 HIV-infected individuals by using a clade B consensus sequence peptide set spanning all HIV proteins. A total of 88% of the 410 tested peptides were recognized, and Nef- and Gag-specific responses dominated the total response for each ethnicity in terms of both breadth and magnitude. Three dominantly targeted regions within these proteins that were recognized by >90% of individuals in each ethnicity were identified. Overall, the total breadth and magnitude of CD8(+)-T-cell responses correlated with individuals' CD4 counts but not with viral loads. The frequency of recognition for each peptide was highly correlated with the relative conservation of the peptide sequence, the presence of predicted immunoproteasomal cleavage sites within the C-terminal half of the peptide, and a reduced frequency of amino acids that impair binding of optimal epitopes to the restricting class I molecules. The present study thus identifies factors that contribute to the immunogenicity of these highly targeted and relatively conserved sequences in HIV that may represent promising vaccine candidates for ethnically heterogeneous populations.


Subject(s)
Ethnicity , HIV Antigens/immunology , HIV/immunology , Immunodominant Epitopes/immunology , T-Lymphocytes, Cytotoxic/immunology , AIDS Vaccines , Black or African American/genetics , Amino Acid Sequence , Anti-Retroviral Agents/pharmacology , CD4 Lymphocyte Count , Cells, Cultured , Entropy , Ethnicity/genetics , Gene Frequency , HIV/chemistry , HIV/drug effects , HIV Antigens/chemistry , Hispanic or Latino/genetics , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class I/immunology , Humans , Immunodominant Epitopes/chemistry , Molecular Sequence Data , Viral Load
4.
Nat Med ; 10(3): 282-9, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14770175

ABSTRACT

Within-patient HIV evolution reflects the strong selection pressure driving viral escape from cytotoxic T-lymphocyte (CTL) recognition. Whether this intrapatient accumulation of escape mutations translates into HIV evolution at the population level has not been evaluated. We studied over 300 patients drawn from the B- and C-clade epidemics, focusing on human leukocyte antigen (HLA) alleles HLA-B57 and HLA-B5801, which are associated with long-term HIV control and are therefore likely to exert strong selection pressure on the virus. The CTL response dominating acute infection in HLA-B57/5801-positive subjects drove positive selection of an escape mutation that reverted to wild-type after transmission to HLA-B57/5801-negative individuals. A second escape mutation within the epitope, by contrast, was maintained after transmission. These data show that the process of accumulation of escape mutations within HIV is not inevitable. Complex epitope- and residue-specific selection forces, including CTL-mediated positive selection pressure and virus-mediated purifying selection, operate in tandem to shape HIV evolution at the population level.


Subject(s)
Evolution, Molecular , HIV Infections/virology , HIV-1/physiology , Mutation , T-Lymphocytes, Cytotoxic/immunology , Adult , Amino Acid Sequence , Child , Epitopes , Female , Genetic Variation , HIV Infections/immunology , HIV Infections/transmission , HIV-1/genetics , HIV-1/immunology , HLA-B Antigens/genetics , HLA-B Antigens/immunology , Humans , Infectious Disease Transmission, Vertical , Likelihood Functions , Phylogeny , Selection, Genetic , T-Lymphocytes, Cytotoxic/metabolism , Viral Load
6.
Phys Rev Lett ; 84(5): 859-62, 2000 Jan 31.
Article in English | MEDLINE | ID: mdl-11017390

ABSTRACT

Magnetized Rydberg positronium forms when an energetic positron ( e(+)) slows within a tungsten crystal and picks up an electron ( e(-)) as it emerges in a strong magnetic field. The signature is equal numbers of e(+) and e(-) when a weak electric field is applied, either of which can be accumulated and counted. The new e(+) accumulation technique is simple, robust, and much more efficient than any other demonstrated to be compatible with a cryogenic vacuum. Possible applications include the study of cold single component plasmas of e(+) and the formation of cold antihydrogen.

8.
West Indian Med J ; 48(1): 16-9, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10375985

ABSTRACT

Organisms of the Mycobacterium fortuitum complex are recognised but uncommon causes of pulmonary disease, primary cutaneous disease and a wide spectrum of nosocomial infections. M fortuitum was isolated from 20 patients over a 15 month period, with an apparent clustering of isolates occurring from January to March 1994. The molecular epidemiology of this clustering was investigated using an arbitrary primer polymerase chain reaction method (AP-PCR). 21 isolates were studied, which yielded 13 distinct profiles. Multiple isolates from a single patient yielded identical profiles. All of seven isolates recovered during the six week period from January to March 1994 shared a common profile which was distinct from all other isolates, suggesting that a single strain was isolated from specimens from all seven patients. The source of this cluster is uncertain. We can find no epidemiological basis for an episode of cross-infection within the hospital environment, and it is assumed that contamination of the specimens during collection, transport or processing was responsible for the "pseudo-outbreak" of M fortuitum.


Subject(s)
Cross Infection/diagnosis , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium fortuitum/classification , AIDS-Related Opportunistic Infections/diagnosis , Bronchiectasis/microbiology , Feces/microbiology , Humans , Lung Diseases, Obstructive/microbiology , Molecular Epidemiology , Mycobacterium fortuitum/genetics , Pneumonia, Bacterial/diagnosis , Polymerase Chain Reaction , Respiratory Tract Infections/diagnosis , Retrospective Studies , Specimen Handling , Sputum/microbiology , Vasculitis/microbiology
9.
West Indian med. j ; 48(1): 16-19, Mar. 1999.
Article in English | LILACS | ID: lil-473126

ABSTRACT

Organisms of the Mycobacterium fortuitum complex are recognised but uncommon causes of pulmonary disease, primary cutaneous disease and a wide spectrum of nosocomial infections. M fortuitum was isolated from 20 patients over a 15 month period, with an apparent clustering of isolates occurring from January to March 1994. The molecular epidemiology of this clustering was investigated using an arbitrary primer polymerase chain reaction method (AP-PCR). 21 isolates were studied, which yielded 13 distinct profiles. Multiple isolates from a single patient yielded identical profiles. All of seven isolates recovered during the six week period from January to March 1994 shared a common profile which was distinct from all other isolates, suggesting that a single strain was isolated from specimens from all seven patients. The source of this cluster is uncertain. We can find no epidemiological basis for an episode of cross-infection within the hospital environment, and it is assumed that contamination of the specimens during collection, transport or processing was responsible for the [quot ]pseudo-outbreak[quot ] of M fortuitum.


Subject(s)
Humans , Cross Infection/diagnosis , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium fortuitum/classification , Specimen Handling , Bronchiectasis/microbiology , Molecular Epidemiology , Sputum/microbiology , Retrospective Studies , Feces/microbiology , AIDS-Related Opportunistic Infections/diagnosis , Respiratory Tract Infections/diagnosis , Mycobacterium fortuitum/genetics , Pneumonia, Bacterial/diagnosis , Lung Diseases, Obstructive/microbiology , Polymerase Chain Reaction , Vasculitis/microbiology
10.
J Cell Sci ; 111 ( Pt 19): 2855-66, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9730978

ABSTRACT

The murine natural resistance-associated macrophage protein, Nramp1, has multiple pleiotropic effects on macrophage activation and regulates survival of intracellular pathogens including Leishmania, Salmonella and Mycobacterium species. Nramp1 acts as an iron transporter, but precisely how this relates to macrophage activation and/or pathogen survival remains unclear. To gain insight into function, anti-Nramp1 monoclonal and polyclonal antibodies are used here to localise Nramp1 following activation and infection. Confocal microscope analysis in uninfected macrophages demonstrates that both the mutant (infection-susceptible) and wild-type (infection-resistant) forms of the protein localise to the membranes of intracellular vesicular compartments. Gold labelling and electron microscopy defines these compartments more precisely as electron-lucent late endosomal and electron-dense lysosomal compartments, with Nramp1 colocalizing with Lamp1 and cathepsins D and L in both compartments, with macrosialin in late endosomes, and with BSA-5 nm gold in pre-loaded lysosomes. Nramp1 is upregulated with interferon-(gamma) and lipopolysaccaride treatment, coinciding with an increase in labelling in lysosomes relative to late endosomes and apparent dispersion of Nramp1-positive vesicles from a perinuclear location towards the periphery of the cytoplasm along the microtubular network. In both control and activated macrophages, expression of the protein is 3- to 4-fold higher in wild-type compared to mutant macrophages. In Leishmania major-infected macrophages, Nramp1 is observed in the membrane of the pathogen-containing phagosomes, which retain a perinuclear localization in resting macrophages. In Mycobacterium avium-infected resting and activated macrophages, Nramp1-positive vesicles migrated to converge, but not always fuse, with pathogen-containing phagosomes. The Nramp1 protein is thus located where it can have a direct influence on phagosome fusion and the microenvironment of the pathogen, as well as in the more general regulation of endosomal/lysosomal function in macrophages.


Subject(s)
Carrier Proteins/immunology , Carrier Proteins/metabolism , Cation Transport Proteins , Macrophages/immunology , Macrophages/metabolism , Membrane Proteins/immunology , Membrane Proteins/metabolism , Amino Acid Sequence , Animals , Antibodies, Monoclonal , Carrier Proteins/genetics , Cell Line , Endosomes/metabolism , Epitope Mapping , Leishmania major/immunology , Leishmania major/pathogenicity , Lysosomes/metabolism , Macrophage Activation , Macrophages/parasitology , Membrane Proteins/genetics , Mice , Microscopy, Confocal , Microscopy, Immunoelectron , Molecular Sequence Data , Mutation , Mycobacterium avium/immunology , Mycobacterium avium/pathogenicity
11.
Curr Biol ; 8(18): 1035-8, 1998 Sep 10.
Article in English | MEDLINE | ID: mdl-9740804

ABSTRACT

The Src homology 2 domain phosphatase-1 (SHP-1) is a tyrosine phosphatase containing two amino-terminal SH2 domains and is expressed primarily by hematopoietic-derived cells [1]. The viable motheaten (Hcphme-v) mutant mice (mev) suffer from progressive inflammation due to a deficiency of SHP-1 enzyme activity [2,3] and die at 3-4 months of age from macrophage and neutrophil accumulation in the lung [4]. The mechanism by which SHP-1 deficiency leads to inflammation is unknown. We found that macrophages from mev mice adhered and spread to a greater extent than normal macrophages through alpha m beta 2 integrin-mediated contacts. Whereas macrophages deficient in the transmembrane tyrosine phosphatase CD45 (CD45-/-) spontaneously detached from alpha m beta 2 integrin contacts [5], cells deficient in both CD45 and SHP-1 did not. In SHP-1 deficient macrophages there was a 10-15-fold increase in D-3 phospholipid products of phosphatidylinositol (PI) 3-kinase. Concomitantly, there was a 2-5-fold increase in membrane-associated PI 3-kinase activity in mev macrophages relative to normal macrophages. Treatment of macrophages with the PI 3-kinase inhibitors wortmannin or LY294002 resulted in a dramatic detachment of cells, indicating that PI 3-kinase activity is required for adhesion. These data demonstrate that SHP-1 is necessary for detachment from alpha m beta 2 integrin-mediated contacts in primary macrophages and suggest that a defect in this pathway may contribute to inflammatory disease.


Subject(s)
Cell Adhesion/physiology , Integrins/physiology , Leukocyte Common Antigens/physiology , Macrophages/physiology , Protein Tyrosine Phosphatases/metabolism , Animals , Bone Marrow Cells/cytology , Inflammation/genetics , Inflammation/physiopathology , Intracellular Signaling Peptides and Proteins , Leukocyte Common Antigens/genetics , Macrophages/cytology , Mice , Mice, Knockout , Mice, Mutant Strains , Phosphatidylinositol 3-Kinases/metabolism , Protein Phosphatase 1 , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/deficiency , Protein Tyrosine Phosphatases/genetics , SH2 Domain-Containing Protein Tyrosine Phosphatases , src Homology Domains
12.
AIDS Res Hum Retroviruses ; 13(16): 1443-6, 1997 Nov 01.
Article in English | MEDLINE | ID: mdl-9359665

ABSTRACT

PIP: Because of the prevalence of leptospirosis in Barbados, patients who present to the hospital with febrile illnesses are routinely screened for Leptospira infection and their sera are stored for future reference. While the majority of patients are infected with Leptospira, some are not. Since some symptoms of acute HIV-1 illness are similar to those of leptospirosis, patient records were reviewed to identify patients whose clinical symptoms may have been due to HIV-1 infection. 10 HIV-1-positive patients originally hospitalized during 1990-94 were identified whose medical histories suggested the occurrence of acute HIV-1 illness at the time of Leptospira testing. Stored sera from those patients were then tested for the presence of HIV-1 p24 antigen and by Western blotting. Evidence of acute HIV-1 infection was considered to be a positive p24 test or a characteristic Western blot profile occurring at or shortly before the time of seropositivity for HIV-1 antibody. The authors determined the sequence of viral RNA from the 12 remaining sera samples from 8 patients, including paired samples drawn at 3- or 4-day intervals from 4 people. The Barbados patient variants aligned more closely with HIV-1 clade B reference strains than with the other subtypes. 2 variants, however, align separately from the classic B subtype and somewhat closer to variants from clades A and C. The Venezuelan isolate, although different from the patient sequences, is also separate from the other B variants.^ieng


Subject(s)
HIV Envelope Protein gp120/genetics , HIV Seropositivity/epidemiology , Leptospirosis/epidemiology , Amino Acid Sequence , Barbados/epidemiology , Diagnosis, Differential , HIV Envelope Protein gp120/classification , HIV Seropositivity/blood , HIV Seropositivity/diagnosis , HIV-1/genetics , Humans , Leptospira , Leptospirosis/diagnosis , Molecular Sequence Data , Retrospective Studies , Sequence Homology, Amino Acid
13.
Curr Biol ; 7(6): 408-17, 1997 Jun 01.
Article in English | MEDLINE | ID: mdl-9197241

ABSTRACT

BACKGROUND: Adhesion of leukocytes to the extracellular matrix and to other cells is mediated by members of the integrin family of adhesion molecules. Src family kinases are activated upon integrin-mediated adhesion. In lymphocytes, CD45 is a leukocyte-specific transmembrane protein tyrosine phosphatase that activates Src family kinases associated with B-cell and T-cell antigen receptor signaling by constitutive dephosphorylation of the inhibitory carboxy-terminal tyrosine phosphorylation site. Here, we show that CD45 is also important in downregulating the kinase activity of Src family members during integrin-mediated adhesion in macrophages. RESULTS: We found that CD45 colocalized with beta2 integrin and the Src family kinase p53/56(lyn) to adhesion sites in bone marrow-derived macrophages. Macrophages from CD45(-/-) mice were unable to maintain integrin-mediated adhesion. In adherent macrophages, absence of CD45 led to the hyperphosphorylation and hyperactivation of p56/59(hck) and p53/56(lyn), but not of p58(c-fgr). CD45 directly inactivated p59(hck) but not p56(lck) in transient transfection assays. Furthermore, coexpression of CD45 with p59(hck) or p56(lyn) containing a tyrosine to phenylalanine mutation at the carboxy-terminal negative regulatory site resulted in decreased tyrosine phosphorylation of the Src family member kinases due to dephosphorylation of the potentiating tyrosine phosphorylation site within the kinase domain. CONCLUSIONS: Using primary bone marrow macrophages, these studies demonstrate that CD45 regulates Src family kinases and is required to maintain macrophage adhesion. CD45 decreases Src family kinase activity by dephosphorylating the tyrosine residue located within the kinase domain.


Subject(s)
CD18 Antigens/metabolism , Integrins/metabolism , Leukocyte Common Antigens/metabolism , Macrophages/physiology , src-Family Kinases/metabolism , Animals , Cell Adhesion , Down-Regulation , Gene Expression Regulation , Mice , Mice, Mutant Strains , Phosphorylation , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-hck
14.
Int J STD AIDS ; 8(6): 393-7, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9179651

ABSTRACT

Descriptions of primary HIV-1 infection have so far been based on Caucasians living in industrialized nations. Due to studies of leptospirosis in the predominantly black population of Barbados, serum was available for patients admitted with acute febrile illnesses to the Queen Elizabeth Hospital (QEH). By searching the medical records of 510 adult patients with known HIV-1 infection we identified 10 patients who had stored serum from an admission for an acute febrile illness that predated or coincided with their first HIV-1-positive test. Serological testing confirmed primary HIV-1 infection in 9 and was suggestive in the 10th patient. The clinical features of these 10 patients were in keeping with previous descriptions of primary HIV-1 infection but differed from leptospirosis cases seen at the QEH. One patient died during his seroconversion illness and another died 3 months after seroconversion. The findings suggest that severe primary HIV-1 infection could be a relatively uncommon occurrence, that the condition may be misdiagnosed, and that cases may not occur until the AIDS epidemic is established.


PIP: A retrospective review was conducted of the medical records of 510 HIV-1-positive adult patients who had attended the Queen Elizabeth Hospital (QEH) to determine whether any had been admitted for an illness compatible with a diagnosis of primary HIV-1 infection. A serum bank, created from patients who had been admitted with acute febrile illnesses and investigated for leptospirosis, provided serological evidence for primary HIV-1 infection in 10 patients. Serological testing of the serum samples confirmed primary HIV-1 infection in nine patients and was suggestive in the tenth. The clinical features of the 10 patients fit the earlier descriptions of primary HIV-1 infection, but differed from the leptospirosis cases seen at the QEH. One patient died during his seroconversion illness and another died 3 months after seroconversion. These findings suggest that severe primary HIV-1 infection could be a relatively uncommon occurrence, that the condition may be misdiagnosed, and that cases may not occur until the AIDS epidemic is established.


Subject(s)
Black People , HIV Infections/epidemiology , HIV-1 , Barbados/epidemiology , HIV Antibodies/blood , HIV Infections/diagnosis , HIV Infections/immunology , HIV Infections/physiopathology , HIV-1/immunology , HIV-1/isolation & purification , Humans
15.
Immunology ; 85(1): 106-13, 1995 May.
Article in English | MEDLINE | ID: mdl-7543444

ABSTRACT

Previous studies have demonstrated that, like bacterial lipopolysaccharide (LPS), arabinofuranosyl-terminated lipoarabinomannan (AraLAM) from an attenuated strain of Mycobacterium induces potent early gene (c-fos, KC, JE and TNF-alpha) responses in murine macrophages, whereas extensively alpha-Manp capped LAM (ManLAM) from virulent M. tuberculosis do not. In this study we have extended analysis of the influence of mycobacterial LAM on macrophage function by demonstrating that AraLAM (but not ManLAM), like bacterial LPS, is a potent stimulator of inducible nitric oxide synthase (iNOS) expression independent of the autocrine activity of co-stimulated tumour necrosis factor-alpha (TNF-alpha) release. The inability of ManLAM to induce iNOS expression was not due to induction of the 'deactivating' cytokine interleukin-10 (IL-10). Indeed, like LPS, AraLAM was also a potent inducer of IL-10 expression. However, analysis of AraLAM- or LPS-induced responses in the presence of interferon-gamma (IFN-gamma) showed that, whereas IFN-gamma acts as a potent co-stimulus for iNOS, it completely inhibits the IL-10 response. Hence, the presence of IFN-gamma early in infection will have an important immunomodulatory role in determining the macrophage response. These results have important implications for the pathogenesis of virulent and avirulent mycobacteria in vivo.


Subject(s)
Amino Acid Oxidoreductases/biosynthesis , Interferon-gamma/immunology , Interleukin-10/biosynthesis , Lipopolysaccharides/immunology , Macrophage Activation/immunology , Animals , Antigens, Bacterial/immunology , Base Sequence , Cells, Cultured , Kinetics , Macrophages/enzymology , Macrophages/immunology , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Mycobacterium/immunology , Nitric Oxide Synthase , Recombinant Proteins , Tumor Necrosis Factor-alpha/biosynthesis
16.
Immunol Lett ; 43(1-2): 99-107, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7737696

ABSTRACT

A common basis to genetic regulation of leishmanial and mycobacterial infections is provided by the action of the murine Lsh/Ity/Bcg gene in controlling the priming/activation of macrophages for antimicrobial activity. This relies on the TNF-alpha-dependent sustained expression of the inducible nitric oxide synthase (iNOS) gene responsible for the generation of large amounts of toxic nitric oxide (NO). The Lsh/Ity/Bcg gene has many pleiotropic effects, including differential expression of the early response gene KC following stimulation of macrophages with bacterial lipopolysaccharide (LPS) and mycobacterial lipoarabinomannan (LAM). The major signal transduction pathway involved in KC induction requires the generation of low levels of NO via constitutive nitric oxide synthase (cNOS) activity, leading to activation of guanylate cyclase and the cGMP-dependent kinase pathway. NO therefore appears to provide a common link between the early influence of Lsh in regulating the expression of genes which mediate many pleiotropic effects, and the later production of NO as the final effector mechanism for kill. The recently cloned candidate for Lsh/Ity/Bcg, designated Nramp for Natural resistance associated macrophage protein, encodes a polytopic integral membrane protein that has structural features common to prokaryotic and eukaryotic transporters and includes a conserved binding-protein-dependent transport motif which may be involved in interaction with peripheral ATP-binding subunits. The N-terminal sequence also carries a proline/serine rich putative SH3 binding domain, consistent with a role for tyrosine kinases in regulating Nramp function. (ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Carrier Proteins/genetics , Cation Transport Proteins , Iron-Binding Proteins , Leishmaniasis/genetics , Macrophage Activation/genetics , Membrane Proteins/genetics , Mycobacterium Infections/genetics , Amino Acid Sequence , Animals , Carrier Proteins/physiology , Genetic Predisposition to Disease , Humans , Leprosy/genetics , Membrane Proteins/physiology , Mice , Molecular Sequence Data , Tuberculosis/genetics
17.
Clin Exp Immunol ; 97(1): 107-12, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8033407

ABSTRACT

Functional studies have shown that the murine macrophage resistance gene Lsh/Ity/Bcg (candidate Nramp) regulates macrophage priming/activation for antimicrobial activity via the tumour necrosis factor-alpha (TNF-alpha)-dependent production of reactive nitrogen intermediates. Since Toxoplasma gondii also parasitizes macrophages, is a stimulator of endogenous TNF-alpha release, and is sensitive to nitric oxide-mediated killing in activated macrophages, studies were carried out using chromosome 1 congenic mouse strains to determine whether Lsh influences T. gondii infection. Two interesting observations were made: (i) contrary to expectation, mice carrying the Lsh-resistant allele died earlier over the acute phase of infection than Lsh-susceptible mice; and (ii) Lsh-resistant mice which survived this acute phase of infection showed lower brain cyst numbers than the Lsh-susceptible mice. Whilst the latter occurred independently of route of inoculation (oral, intraperitoneal, or subcutaneous), the former was influenced both by the route of inoculation and the genetic background on which the Lsh-resistant allele had been isolated. Hence, following oral administration of 20 brain cysts of the RRA strain of T. gondii, mice carrying the Lsh-resistant allele on a B10 genetic background showed a significantly enhanced rate of mortality over the acute (first 8-12 days) phase of infection than B10 Lsh-susceptible mice. Although this acute phase of infection in B10 background mice was accompanied by an increase in serum TNF-alpha levels in both Lsh-resistant and -susceptible mouse strains, early mortality preceded the TNF-alpha peak, and administration of neutralizing rabbit anti-TNF-alpha did not significantly enhance survival. Hence, inflammatory mediators other than TNF-alpha appear to be responsible for the increased rate of acute mortality observed in resistant mice. Infection intraperitoneally led to delayed mortality in B10 mice, with the mean time to 50% mortality now being significantly longer in Lsh-resistant than in Lsh-susceptible mice. On a BALB genetic background, it was the i.p. route of infection which led to acute mortality and more rapid death in the Lsh-resistant strain. When a less virulent inoculum was used and mortality delayed, Lsh-susceptible mice died more rapidly, and i.p. administration of rabbit anti-TNF-alpha led to 100% mortality between days 8 and 10 of infection in both susceptible and resistant mouse strains, consistent with a crucial protective role for TNF-alpha during this phase of infection.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Macrophage Activation/genetics , Macrophage Activation/immunology , Toxoplasmosis, Animal/genetics , Toxoplasmosis, Animal/immunology , Animals , Antibodies/administration & dosage , Female , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Neutralization Tests , Species Specificity , Tumor Necrosis Factor-alpha/biosynthesis
18.
Immunology ; 82(1): 42-50, 1994 May.
Article in English | MEDLINE | ID: mdl-8045593

ABSTRACT

The murine resistance gene Lsh/Ity/Bcg regulates activation of macrophages for tumour necrosis factor-alpha (TNF-alpha)-dependent production of nitric oxide mediating antimicrobial activity against Leishmania, Salmonella and Mycobacterium. As Lsh is differentially expressed in macrophages from different tissue sites, experiments were performed to determine whether interaction with extracellular matrix (ECM) proteins would influence the macrophage TNF-alpha response. Plating of bone marrow-derived macrophages onto purified fibrinogen or fibronectin-rich L929 cell-derived matrices, but not onto mannan, was itself sufficient to stimulate TNF-alpha release, with significantly higher levels released from congenic B10.L-Lshr compared to C57BL/10ScSn (Lshs) macrophages. Only macrophages plated onto fibrinogen also released measurable levels of nitrites, again higher in Lshr compared to Lshs macrophages. Addition of interferon-gamma (IFN-gamma), but not bacterial lipopolysaccharide or mycobacterial lipoarabinomannan, as a second signal enhanced the TNF-alpha and nitrite responses of macrophages plated onto fibrinogen, particularly in the Lshr macrophages. Interaction with fibrinogen and fibronectin also primed macrophages for an enhanced TNF-alpha response to leishmanial parasites, but this was only translated into enhanced nitrite responses in the presence of IFN-gamma. In these experiments, Lshr macrophages remained superior in their TNF-alpha responses throughout, but to a degree which reflected the magnitude of the difference observed on ECM alone. Hence, the specificity for the enhanced TNF-alpha responses of Lshr macrophages lay in their interaction with fibrinogen and fibronectin ECM, while a differential nitrite response was only observed with fibrinogen and/or IFN-gamma. The results are discussed in relation to the possible function of the recently cloned candidate gene Nramp, which has structural identity to eukaryote transporters and an N-terminal cytoplasmic proline/serine-rich putative SH3 binding domain.


Subject(s)
Extracellular Matrix Proteins/immunology , Gene Expression Regulation/immunology , Macrophage Activation/immunology , Nitrites/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Antigens, Protozoan/immunology , Bone Marrow/immunology , Cells, Cultured , Fibrinogen/immunology , Fibronectins/immunology , Interferon-gamma/immunology , Leishmania/immunology , Lipopolysaccharides/immunology , Macrophages/immunology , Mice , Mice, Inbred C57BL , Mice, Inbred Strains
19.
J Exp Med ; 179(5): 1683-7, 1994 May 01.
Article in English | MEDLINE | ID: mdl-7513015

ABSTRACT

The Lsh/Ity/Bcg locus on mouse chromosome 1 regulates macrophage (m phi) priming/activation for antimicrobial activity against intracellular pathogens. A candidate Bcg gene, designated natural resistance-associated m phi protein (Nramp), recently isolated from a pre-B cell cDNA library encodes a polytopic integral membrane protein with structural features common to prokaryotic and eukaryotic transporters. In the present study, an activated m phi cDNA library yielded new Nramp clones that differ in the 5' region from the published pre-B cell-derived clone sequence, resulting in addition of 64 amino acids at the NH2 terminus of the predicted protein. This new domain is rich in proline, serine, and basic amino acids, and includes three protein kinase C phosphorylation sites and a putative Src homology 3 binding domain. RNAs containing this domain are the only form found in the m phi. Hence, the protein encoded by this RNA is the candidate molecule mediating natural resistance to intra-m phi pathogens.


Subject(s)
Carrier Proteins/biosynthesis , Cation Transport Proteins , Iron-Binding Proteins , Macrophages/metabolism , Membrane Proteins/biosynthesis , Amino Acid Sequence , Base Sequence , Blotting, Northern , Carrier Proteins/chemistry , Cloning, Molecular , DNA , Membrane Proteins/chemistry , Molecular Sequence Data , Proline/metabolism , Proto-Oncogene Proteins pp60(c-src) , Sequence Homology , Serine/metabolism
20.
Infect Immun ; 62(4): 1176-84, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8132324

ABSTRACT

The murine chromosome 1 gene Lsh/Ity/Bcg (candidate Nramp) regulates macrophage activation for antimicrobial activity against Salmonella typhimurium, Leishmania donovani, and Mycobacterium spp. To determine early events in the activation pathway, the ability of mycobacterial lipoarabinomannan (LAM) to induce early gene (KC and JE) expression in macrophages from susceptible (S) C57BL/10ScSn (Lshs) and congenic resistant (R) B10.L-Lshr mice was investigated. Stimulation with 1.8 microgram of arabinofuranosyl-terminated LAM (AraLAM) per ml resulted in similar kinetics for KC or JE expression in S and R macrophages. However, whereas JE/glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA ratios remained equivalent, R macrophages consistently showed enhanced KC/GAPDH ratios within 30 to 40 min of stimulation compared with S macrophages. Significant differences in KC/GAPDH ratios were observed throughout the peak period (0.5 to 6 h) of the KC response and with doses of AraLAM ranging from 0.01 to 2.5 micrograms/ml. Heavily mannosylated LAM from virulent Mycobacterium tuberculosis Erdman, in doses of up to 2.5 micrograms/ml, failed to stimulate KC or JE in S or R macrophages. Gamma interferon alone (25 U/ml) stimulated equivalent JE expression in S and R macrophages and synergized with AraLAM to enhance JE in both. In contrast, AraLAM-induced KC expression was inhibited in the presence of gamma interferon. Agonist/inhibitor studies were undertaken to determine the signal transduction pathways mediating KC expression. The protein kinase C (PKC) inhibitor Calphostin C (200 nM) inhibited AraLAM-induced KC by 34% +/- 4% in S macrophages and 43% +/- 5% in R macrophages; the cyclic AMP-dependent PKA inhibitor KT5720 (2 microM) inhibited AraLAM-induced KC by 33% +/- 4% (S) and 25% +/- 5% (R). A role for Ca2+ was indicated because ionophore alone stimulated KC expression and synergized with AraLAM to give a dramatically enhanced response. Induction of KC was also inhibited by (i) blocking constitutive nitric oxide (NO) production by preincubation of macrophages with NG-monomethyl-L-arginine (400 microM) (48% +/- 8% [S] and 40% +/- 11% [R]) and (ii) incubation of macrophages with the cyclic GMP-dependent kinase inhibitor KT5823 (4 microM) (65% +/- 4% [S] and 72% +/- 6% [R]). The manner in which these PKC-, PKA-, and Ca(2+)-dependent, NO-mediated cyclic GMP-dependent kinase signal transduction pathways may relate to function of the candidate Lsh/Ity/Bcg gene Nramp is discussed.


Subject(s)
Carrier Proteins/genetics , Cation Transport Proteins , Chemotactic Factors/genetics , Cytokines/genetics , Gene Expression Regulation , Iron-Binding Proteins , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Membrane Proteins/genetics , Animals , Cells, Cultured , Chemokine CCL2 , Chemokine CXCL1 , Chemokines , Chemokines, CXC , Dose-Response Relationship, Drug , Interferon-gamma/pharmacology , Mice , Mice, Inbred C57BL , Mycobacterium/pathogenicity , Nitric Oxide/physiology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...